GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jiangsu Deyuan Pharmaceutical Co Ltd (BJSE:832735) » Definitions » Ending Cash Position

Jiangsu Deyuan Pharmaceutical Co (BJSE:832735) Ending Cash Position : ¥169.1 Mil (As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is Jiangsu Deyuan Pharmaceutical Co Ending Cash Position?

Jiangsu Deyuan Pharmaceutical Co's Ending Cash Position for the quarter that ended in Mar. 2025 was ¥169.1 Mil.

Jiangsu Deyuan Pharmaceutical Co's quarterly Ending Cash Position increased from Sep. 2024 (¥301.1 Mil) to Dec. 2024 (¥304.0 Mil) but then declined from Dec. 2024 (¥304.0 Mil) to Mar. 2025 (¥169.1 Mil).

Jiangsu Deyuan Pharmaceutical Co's annual Ending Cash Position increased from Dec. 2022 (¥258.2 Mil) to Dec. 2023 (¥442.0 Mil) but then declined from Dec. 2023 (¥442.0 Mil) to Dec. 2024 (¥304.0 Mil).

Jiangsu Deyuan Pharmaceutical Co Ending Cash Position Historical Data

The historical data trend for Jiangsu Deyuan Pharmaceutical Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangsu Deyuan Pharmaceutical Co Ending Cash Position Chart

Jiangsu Deyuan Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 77.65 366.23 258.16 441.98 303.98

Jiangsu Deyuan Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 518.31 305.15 301.07 303.98 169.11

Jiangsu Deyuan Pharmaceutical Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Jiangsu Deyuan Pharmaceutical Co's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=441.981+-138.002
=304.0

Jiangsu Deyuan Pharmaceutical Co's Ending Cash Position for the quarter that ended in Mar. 2025 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=303.979+-134.87
=169.1

Jiangsu Deyuan Pharmaceutical Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Jiangsu Deyuan Pharmaceutical Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Jiangsu Deyuan Pharmaceutical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jiangsu Deyuan Pharmaceutical Co Ltd (BJSE:832735) » Definitions » Ending Cash Position
Comparable Companies
SZSE:000919 SHSE:688373 SZSE:002728 SHSE:600829 SZSE:002644 SZSE:002923 SHSE:603207 SHSE:688799 SHSE:603351 SZSE:300485 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA
Traded in Other Exchanges
N/A
Address
No. 29, Changjiang Road, Economic and Technological Development Zone, Jiangsu Province, Lianyungang, CHN, 222047
Website
https://www.pharmdy.com
Jiangsu Deyuan Pharmaceutical Co Ltd is involved in the R&D, production and sales of tablets, hard capsules and APIs.

Jiangsu Deyuan Pharmaceutical Co Headlines

No Headlines